The NR4A subfamily of nuclear receptors: potential new therapeutic targets for the treatment of inflammatory diseases

DOI Web Site 3 Citations
  • Ricardo Rodríguez-Calvo
    Vascular Medicine and Metabolism Unit, Research Unit on Lipids and Atherosclerosis, Sant Joan University Hospital, Pere Virgili Health Research Institute (IISPV) and Spanish Biomedical Research Centre in Diabetes and Associated Metabolic Disorders (CIBERDEM)-Instituto de Salud Carlos III, Faculty of Medicine and Health Sciences, Rovira i Virgili University, Reus, Spain
  • Marta Tajes
    Heart Diseases Biomedical Research Group, Inflammatory and Cardiovascular Disorders Program, Hospital del Mar Medical Research Institute (IMIM), Parc de Salut Mar, Barcelona, Spain
  • Manuel Vázquez-Carrera
    Department of Pharmacology, Toxicology and Therapeutic Chemistry, Institut de Biomedicina de la Universitat de Barcelona (IBUB), Institut de Recerca Pediàtrica-Hospital Sant Joan de Déu, and Spanish Biomedical Research Centre in Diabetes and Associated Metabolic Disorders (CIBERDEM)-Instituto de Salud Carlos III, Faculty of Pharmacy, Diagonal 643, University of Barcelona, Barcelona, Spain

Journal

Citations (3)*help

See more

Details 詳細情報について

Report a problem

Back to top